2016
DOI: 10.1080/15384047.2016.1139240
|View full text |Cite
|
Sign up to set email alerts
|

Progesterone receptor membrane component 1 promotes survival of human breast cancer cells and the growth of xenograft tumors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

9
30
1
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 50 publications
(41 citation statements)
references
References 76 publications
9
30
1
1
Order By: Relevance
“…We were interested in whether DNA mutation rates may have been related to the P4-dependent protection against cell death, or to the mechanism of AG-205-induced cell death. Consistent with previously reported PGRMC1dependent anti-mitotic effects of P4 in Ishikawa endometrial cancer cells [36] and MDA-MB-231 breast cancer cells [47], incubation of cells in 1 μM P4 retarded cell proliferation of all cells over-expressing a PGRMC1-HA protein (WT, DM or TM), but not of MP cells relative to non-P4-treated control cells ( Fig. 2a).…”
Section: Pgrmc1 Phosphorylation Mutants Did Not Affect P4 or Ag-205 Rsupporting
confidence: 92%
“…We were interested in whether DNA mutation rates may have been related to the P4-dependent protection against cell death, or to the mechanism of AG-205-induced cell death. Consistent with previously reported PGRMC1dependent anti-mitotic effects of P4 in Ishikawa endometrial cancer cells [36] and MDA-MB-231 breast cancer cells [47], incubation of cells in 1 μM P4 retarded cell proliferation of all cells over-expressing a PGRMC1-HA protein (WT, DM or TM), but not of MP cells relative to non-P4-treated control cells ( Fig. 2a).…”
Section: Pgrmc1 Phosphorylation Mutants Did Not Affect P4 or Ag-205 Rsupporting
confidence: 92%
“…We were interested in whether DNA mutation rates may have been related to the P4dependent protection against cell death, or to the mechanism of AG-205-indiced cell death. Consistent with previously reported PGRMC1-dependent anti-mitotic effects of P4 in Ishikawa endometrial cancer cells (Friel et al, 2015) and MDA-MB-231 breast cancer cells (Clark et al, 2016), incubation of cells in 1μM P4 retarded cell proliferation of all cells over-expressing a PGRMC1-HA protein (WT, DM or TM), but not of MP cells relative to non-P4-treated control cells ( Figure 3A). When cells pretreated with or without P4 for 1 hr were co-incubated in the presence doxorubicin (Dox), in the absence of P4 then WT, DM and TM cells were more susceptible to Dox-induced death ( Figure 3B-C, white data points and boxes), however these cells exhibited greater P4-dependent protection against Dox-induced death ( Figure 3B-C, shaded data points and boxes).…”
Section: Pgrmc1 Phosphorylation Mutants Did Not Affect P4 or Ag-205 Rsupporting
confidence: 92%
“…This finding is in accordance with the experimental evidences that PGRMC1 depletion suppresses cancer cells proliferation in vitro and tumor growth in vivo in all the types of cancers studied so far. 10,19,[36][37][38] Moreover, the observation that PGRMC1 is overexpressed in a wide range of tumors when compared to corresponding normal tissues 19,[39][40][41][42] further support this hypothesis. In this view PGRMC1 overexpression would sustain propagation of abnormal cancer cells, helping them to escape mitotic catastrophe.…”
Section: Discussionsupporting
confidence: 63%